{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T10:50:56Z","timestamp":1648637456290},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s00115-005-1942-5","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T09:34:49Z","timestamp":1118655289000},"page":"1009-1023","source":"Crossref","is-referenced-by-count":1,"title":["Immunneuropathien \u2014 Aktuelle Aspekte der Diagnostik und Therapie"],"prefix":"10.1007","volume":"76","author":[{"given":"R.","family":"Gold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bayas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. V.","family":"Toyka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1942_CR1","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27","author":"Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barre syndrome [see comments]. Ann Neurol 27 [Suppl]:S21\u2013S24","journal-title":"Ann Neurol"},{"key":"1942_CR2","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00415-002-0808-z","volume":"249","author":"Comi","year":"2002","unstructured":"Comi G, Roveri L, Swan A et al. (2002) A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol 249:1370\u20131377","journal-title":"J Neurol"},{"key":"1942_CR3","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.410360607","volume":"36","author":"Dyck","year":"1994","unstructured":"Dyck PJ, Litchy WJ, Kratz KM et al. (1994) A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36:838\u2013845","journal-title":"Ann Neurol"},{"key":"1942_CR4","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199111213252105","volume":"325","author":"Dyck","year":"1989","unstructured":"Dyck PJ, Low PA, Windebank AJ et al. (1989) Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 325:1482\u20131486","journal-title":"N Engl J Med"},{"key":"1942_CR5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1474-4422(03)00264-3","volume":"2","author":"Gold","year":"2003","unstructured":"Gold R, Dalakas MC, Toyka KV (2003) Immunotherapy in autoimmune neuromuscular disorders. Lancet Neurol 2:22\u201332","journal-title":"Lancet Neurol"},{"key":"1942_CR6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2003-41133","volume":"23","author":"Gold","year":"2003","unstructured":"Gold R, Fontana A, Zierz S (2003) Therapy of neurological disorders in systemic vasculitis. Semin Neurol 23:207\u2013214","journal-title":"Semin Neurol"},{"key":"1942_CR7","first-page":"34","volume":"18","author":"Gold","year":"1999","unstructured":"Gold R, Reiners K, Toyka KV (1999) Pathogenese und Behandlungsstrategien des akuten Guillain-Barre Syndroms. Nervenheilkunde 18:34\u201339","journal-title":"Nervenheilkunde"},{"key":"1942_CR8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","volume":"119","author":"Hahn","year":"1996","unstructured":"Hahn AF, Bolton CF, Pillay N et al. (1996) Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy\u2014A double-blind, sham-controlled, cross-over study. Brain 119:1055\u20131066","journal-title":"Brain"},{"key":"1942_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.880180202","volume":"18","author":"Hartung","year":"1995","unstructured":"Hartung HP, Pollard JD, Harvey GK et al. (1995) Immunopathogenesis and treatment of the Guillain-Barr\u00e9 syndrome. Part I. Muscle Nerve 18:137\u2013153","journal-title":"Muscle Nerve"},{"key":"1942_CR10","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/brain\/118.5.1263","volume":"118","author":"Harvey","year":"1995","unstructured":"Harvey GK, Gold R, Toyka KV et al. (1995) Nonneural-specific T lymphocytes can orchestrate inflammatory peripheral neuropathy. Brain 118:1263\u20131272","journal-title":"Brain"},{"key":"1942_CR11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","volume":"50","author":"Hughes","year":"2001","unstructured":"Hughes R, Bensa S, Willison H et al. (2001) Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50:195\u2013201","journal-title":"Ann Neurol"},{"key":"1942_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.20076","volume":"30","author":"Kieseier","year":"2004","unstructured":"Kieseier BC, Kiefer R, Gold R et al. (2004) Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30:131\u2013156","journal-title":"Muscle Nerve"},{"key":"1942_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1474-4422(04)00822-1","volume":"3","author":"Martini","year":"2004","unstructured":"Martini R, Toyka KV (2004) Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients. Lancet Neurol 3:457\u2013465","journal-title":"Lancet Neurol"},{"key":"1942_CR14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00019052-200210000-00013","volume":"15","author":"Maurer","year":"2002","unstructured":"Maurer M, Gold R (2002) Animal models of immune-mediated neuropathies. Curr Opin Neurol 15:617\u2013622","journal-title":"Curr Opin Neurol"},{"key":"1942_CR15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.nmd.2004.02.013","volume":"14","author":"Maurer","year":"2004","unstructured":"Maurer M, Stoll G, Toyka KV (2004) Multifocal motor neuropathy presenting as chronic progressive proximal leg weakness. Neuromuscul Disord 14:380\u2013382","journal-title":"Neuromuscul Disord"},{"key":"1942_CR16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(01)00266-1","volume":"115","author":"Nobile-Orazio","year":"2001","unstructured":"Nobile-Orazio E (2001) Multifocal motor neuropathy. J Neuroimmunol 115:4\u201318","journal-title":"J Neuroimmunol"},{"key":"1942_CR17","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1212\/WNL.51.6_Suppl_5.S22","volume":"51","author":"Pestronk","year":"1998","unstructured":"Pestronk A (1998) Multifocal motor neuropathy: diagnosis and treatment. Neurology 51:S22\u2013S24","journal-title":"Neurology"},{"key":"1942_CR18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/mus.10359","volume":"27","author":"Renaud","year":"2003","unstructured":"Renaud S, Gregor M, Fuhr P et al. (2003) Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Muscle Nerve 27:611\u2013615","journal-title":"Muscle Nerve"},{"key":"1942_CR19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","volume":"24","author":"Saperstein","year":"2001","unstructured":"Saperstein DS, Katz JS, Amato AA et al. (2001) Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24:311\u2013324","journal-title":"Muscle Nerve"},{"key":"1942_CR20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00019052-199808000-00006","volume":"11","author":"Steck","year":"1998","unstructured":"Steck AJ, Schaeren-Wiemers N, Hartung HP (1998) Demyelinating inflammatory neuropathies, including Guillain-Barre syndrome [published erratum appears in Curr Opin Neurol 1998 Dec;11(6):739]. Curr Opin Neurol 11:311\u2013318","journal-title":"Curr Opin Neurol"},{"key":"1942_CR21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00019052-199606000-00016","volume":"9","author":"Toyka","year":"1996","unstructured":"Toyka KV, Hartung HP (1996) Chronic inflammatory polyneuritis and neuropathies. Curr Opin Neurol 9:240\u2013250","journal-title":"Curr Opin Neurol"},{"key":"1942_CR22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","volume":"363","author":"Van Koningsveld","year":"2004","unstructured":"Van Koningsveld R, Schmitz PIM, van der Meche FGA et al. (2004) Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial. Lancet 363:192\u2013196","journal-title":"Lancet"},{"key":"1942_CR23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1750-3639.2001.tb00407.x","volume":"11","author":"Vital","year":"2001","unstructured":"Vital A (2001) Paraproteinemic neuropathies. Brain Pathol 11:399\u2013407","journal-title":"Brain Pathol"},{"key":"1942_CR24","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","volume":"125","author":"Willison","year":"2002","unstructured":"Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591\u20132625","journal-title":"Brain"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-005-1942-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-005-1942-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-005-1942-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:00:47Z","timestamp":1558587647000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-005-1942-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["1942"],"URL":"https:\/\/doi.org\/10.1007\/s00115-005-1942-5","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}